Poland vs Singapore: Treatment for hypertension, male
Poland
56.2%
in 2019
Singapore
58.9%
in 2019
Poland rank
13th
Singapore rank
10th
Treatment for hypertension, male over time
- Poland
- Singapore
How they compare
Singapore currently reports 58.9% against 56.2% in Poland, a difference of 2.7%.
Across all 30 years both countries report, Singapore has been ahead every year.
Poland ranks 13th and Singapore ranks 10th of 192 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Poland | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 24.6% | 33.8% | 9.2% | Singapore |
| 2000s | 36.3% | 44.9% | 8.6% | Singapore |
| 2010s | 50.0% | 55.4% | 5.5% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, male, Poland or Singapore?
- Singapore, at 58.9% against 56.2% in Poland as of 2019.
- What is the difference in treatment for hypertension, male between Poland and Singapore?
- 2.7%, with Singapore ahead.
- How many years of comparable data are there for Poland and Singapore?
- 30 years are reported by both, from 1990 to 2019.
- How do Poland and Singapore rank globally for treatment for hypertension, male?
- Poland ranks 13th and Singapore ranks 10th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.